A short, 60 seconds read that summarises 4 handpicked articles that are worth reading about:
Why is the number of advanced therapy medicinal product (ATMP) withdrawals from the European market rising?
Top 10 most anticipated drug launches of 2022
What is the reformed early access scheme in France?
NICE recommends new drug for people living with obesity
Discover the latest developments in AIFA reform as delays persist with the extension of CTS and CPR ...
French government's ambitious plan to save €1 billion in healthcare expenses by 2024 through new r...
Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.
Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.